Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease

Objectives: Due to the chronic inflammatory status, specific neuro-hormones and progression of arterial stiffness, patients with rheumatoid arthritis (RA) are exposed to the development of excessive left ventricular mass disproportionate to the need to compensate left ventricular load. This condition, named inappropriately high left ventricular mass (iLVM), is associated with unfavorable prognosis in patients with hypertension, aortic stenosis or diabetes. In this study, we assessed prevalence and factors associated with iLVM in a large cohort of patients with RA and tested the hypothesis that RA per se is a condition related to iLVM. Methods: We prospectively analyzed 235 RA patients without overt cardiac disease recruited between January and December 2014, who were compared with 235 controls matched for age, sex, BMI, prevalence of hypertension and diabetes. iLVM was defined as measured/predicted LVM ratio above 123%. LVM was predicted in each individual by using a simple equation considering height, sex and left ventricular work. Results: iLVM was detected in 150 RA patients (64%) and in 30 controls (15%; P < 0.001). In patients with RA, the variables independently associated with iLVM emerged by multivariate logistic regression analysis were left ventricular systolic dysfunction measured as mid-wall shortening and concentric left ventricular geometry. Considering both groups of patients with RA and matched controls, RA was the strongest variable related to iLVM (odds ratio 3.37, 95% confidence interval 1.37–8.31, P = 0.008). Conclusions: Two-thirds of patients with RA without overt cardiac disease have iLVM, which is associated with left ventricular systolic dysfunction and concentric geometry. RA per se is a condition closely related to iLVM.

[1]  M. Takei,et al.  Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging , 2014, The Journal of Rheumatology.

[2]  G. Cioffi,et al.  Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. , 2013, International journal of cardiology.

[3]  T. Therneau,et al.  Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. , 2013, Arthritis and rheumatism.

[4]  A. di Lenarda,et al.  Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study , 2012, European journal of preventive cardiology.

[5]  M. Turiel,et al.  Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. , 2012, International journal of cardiology.

[6]  Andrea Rossi,et al.  Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[7]  G. Cioffi,et al.  Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis , 2012, Journal of hypertension.

[8]  A. di Lenarda,et al.  Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study , 2011, Journal of hypertension.

[9]  T. Therneau,et al.  The Influence of Rheumatoid Arthritis Disease Characteristics on Heart Failure , 2011, The Journal of Rheumatology.

[10]  L. Tarantini,et al.  Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events , 2011, Journal of hypertension.

[11]  L. Tarantini,et al.  Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis , 2010, Heart.

[12]  M. Szklo,et al.  Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. , 2010, Arthritis and rheumatism.

[13]  G. Cioffi,et al.  Compensatory or inappropriate left ventricular mass in different models of left ventricular pressure overload: comparison between patients with aortic stenosis and arterial hypertension , 2009, Journal of hypertension.

[14]  T. Therneau,et al.  The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. , 2008, Arthritis and rheumatism.

[15]  F. Flachskampf,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[16]  J. Lekakis,et al.  Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis , 2008, Circulation.

[17]  E. Tadamura,et al.  Relation among Left Ventricular Mass, Insulin Resistance, and Hemodynamic Parameters in Type 2 Diabetes , 2008, Hypertension Research.

[18]  G. de Simone,et al.  Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities , 2007, Journal of hypertension.

[19]  W. Ollier,et al.  HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[20]  J. Avorn,et al.  Patterns of cardiovascular risk in rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[21]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[22]  S. Gabriel,et al.  The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. , 2005, Arthritis and rheumatism.

[23]  S. Daniels,et al.  Evaluation of Concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation , 2005, Hypertension.

[24]  H. Dige-Petersen,et al.  Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy , 2004, Journal of Human Hypertension.

[25]  F. Wolfe,et al.  Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. , 2004, The American journal of medicine.

[26]  H. Koyama,et al.  Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[27]  D. Levy,et al.  Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality: The Framingham Heart Study , 2003, Circulation.

[28]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[29]  G. de Simone,et al.  Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study , 2002, Hypertension.

[30]  G. de Simone,et al.  Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy , 2001, Journal of hypertension.

[31]  M. Nieminen,et al.  Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. , 2001, American heart journal.

[32]  G. Mensah,et al.  Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension , 2001, Journal of hypertension.

[33]  S. Daniels,et al.  Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. , 1998, Hypertension.

[34]  J. Laragh,et al.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. , 1995, Journal of the American College of Cardiology.

[35]  J. Laragh,et al.  Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. , 1994, Journal of the American College of Cardiology.

[36]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[37]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[38]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[39]  J. Schwartz,et al.  Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. , 2009, Arthritis and rheumatism.

[40]  櫻井 真由美,et al.  Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis , 2004 .

[41]  A. Jenkins,et al.  Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. , 2003, Arthritis and rheumatism.

[42]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.